Evaluation of Pancytopenia

Initial Laboratory Assessment

The American College of Physicians recommends confirming true pancytopenia by obtaining a complete blood count with manual differential to exclude pseudothrombocytopenia from EDTA-dependent platelet clumping 1, 2
A peripheral blood smear examination by a qualified hematologist or pathologist is essential to identify schistocytes, giant platelets, dysplastic features, abnormal cells, and megaloblastic changes 1, 2, 3
The reticulocyte count differentiates decreased bone marrow production from peripheral destruction 1, 2

The National Comprehensive Cancer Network recommends checking vitamin B12 and folate levels early, as severe B12 deficiency can mimic hematologic malignancy with pancytopenia, lymphadenopathy, and fever 3, 1, 2
Infectious disease screening should include HIV testing, hepatitis B and C virus screening, and consideration of other chronic infections based on exposure history 1, 2

The National Comprehensive Cancer Network recommends that both bone marrow aspiration and biopsy must be performed simultaneously in most cases of pancytopenia 3, 1
The bone marrow evaluation should include morphological assessment, cellularity assessment, percentage of marrow blasts, presence or absence of ringed sideroblasts, degree of fibrosis, immunophenotyping by flow cytometry, and cytogenetic analysis 3, 1, 2

For suspected hemophagocytic lymphohistiocytosis, testing should include ferritin, triglycerides, fibrinogen, and clinical evaluation for fever and hepatosplenomegaly 1, 2
For potential stem cell transplant candidates, HLA typing, CMV status, and full HLA typing should be performed 3, 2

Hospital admission is recommended for patients with newly diagnosed pancytopenia and platelet count <20 × 10⁹/L, social concerns, diagnostic uncertainty, significant comorbidities, or more significant mucosal bleeding 1, 2

The American College of Physicians recommends not missing megaloblastic anemia, which is a common cause of pancytopenia and is completely reversible with vitamin replacement 4
The European Society for Medical Oncology recommends not relying on clinical symptoms alone for fungal infections in pancytopenic patients, as signs are non-specific and bacterial versus fungal bloodstream infections cannot be clinically differentiated 5